March 29 2022
Webinar
Monitor HCP clearance for expression systems without access to an ELISA kit
Now you can rethink your HCP assay strategy with mass spectrometry (MS)-based HCP analysis available from a GMP-certified lab. It is ideal when there is no sufficient generic ELISA for your cell line – or when the time to develop a process-specific ELISA is limited, e.g., for phase 2 and 3 clinical trials.
An MS-based assay has very high HCP coverage and sensitivity and is customizable within weeks. It even enables the identification and quantification of individual HCPs – for instance, across batches for easy comparison of purification strategies. The assay is available for full validation following ICH guidelines and thus accessible for release testing and commercial production.